These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 9215308

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hyperinsulinemia in postpubertal girls with a history of premature pubarche and functional ovarian hyperandrogenism.
    Ibanez L, Potau N, Zampolli M, Prat N, Virdis R, Vicens-Calvet E, Carrascosa A.
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1237-43. PubMed ID: 8772605
    [Abstract] [Full Text] [Related]

  • 5. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.
    Apter D, Bützow T, Laughlin GA, Yen SS.
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2966-73. PubMed ID: 7559882
    [Abstract] [Full Text] [Related]

  • 6. Elevated free IGF-I levels in prepubertal Hispanic girls with premature adrenarche: relationship with hyperandrogenism and insulin sensitivity.
    Silfen ME, Manibo AM, Ferin M, McMahon DJ, Levine LS, Oberfield SE.
    J Clin Endocrinol Metab; 2002 Jan; 87(1):398-403. PubMed ID: 11788683
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The roles of insulin sensitivity, insulin-like growth factor I (IGF-I), and IGF-binding protein-1 and -3 in the hyperandrogenism of African-American and Caribbean Hispanic girls with premature adrenarche.
    Vuguin P, Linder B, Rosenfeld RG, Saenger P, DiMartino-Nardi J.
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2037-42. PubMed ID: 10372707
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Insulin-like growth factor I, its binding proteins 1 and 3, and growth hormone-binding protein in children and adolescents with insulin-dependent diabetes mellitus: clinical implications.
    Muñoz MT, Barrios V, Pozo J, Argente J.
    Pediatr Res; 1996 Jun; 39(6):992-8. PubMed ID: 8725260
    [Abstract] [Full Text] [Related]

  • 14. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
    Juul A, Scheike T, Nielsen CT, Krabbe S, Müller J, Skakkebaek NE.
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Normative data for insulin-like growth factors (IGFs), IGF-binding proteins, and growth hormone-binding protein in a healthy Spanish pediatric population: age- and sex-related changes.
    Argente J, Barrios V, Pozo J, Muñoz MT, Hervás F, Stene M, Hernández M.
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1522-8. PubMed ID: 7505288
    [Abstract] [Full Text] [Related]

  • 17. Insulin-like growth factor binding protein-I levels are strongly associated with insulin sensitivity and obesity in early pubertal children.
    Travers SH, Labarta JI, Gargosky SE, Rosenfeld RG, Jeffers BW, Eckel RH.
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1935-9. PubMed ID: 9626122
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.